Michael Matson
Stock Analyst at Needham
(2.70)
# 1,884
Out of 4,829 analysts
23
Total ratings
69.23%
Success rate
11.46%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Buy | $408 → $423 | $125.11 | +238.10% | 4 | Jan 31, 2020 | |
| INGN Inogen | Upgrades: Buy | $90 | $6.23 | +1,345.78% | 2 | Nov 6, 2019 | |
| MMSI Merit Medical Systems | Initiates: Buy | $53 | $95.83 | -44.69% | 1 | Apr 20, 2018 | |
| GMED Globus Medical | Upgrades: Buy | n/a | $55.82 | - | 1 | Apr 4, 2018 | |
| RMD ResMed | Upgrades: Hold | n/a | $245.04 | - | 1 | Jan 23, 2018 | |
| BSX Boston Scientific | Upgrades: Strong Buy | n/a | $102.86 | - | 1 | Dec 8, 2017 | |
| LIVN LivaNova | Upgrades: Buy | n/a | $44.06 | - | 2 | Sep 15, 2017 | |
| SYK Stryker | Upgrades: Hold | n/a | $380.92 | - | 4 | Aug 25, 2017 | |
| MBLY Mobileye Global | Downgrades: Hold | n/a | $16.30 | - | 1 | Mar 14, 2017 | |
| HOLX Hologic | Upgrades: Buy | n/a | $56.75 | - | 2 | Feb 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $60.50 | - | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.93 | - | 1 | Mar 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.16 | - | 1 | Feb 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $37.74 | - | 1 | Jan 29, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $125.11
Upside: +238.10%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $6.23
Upside: +1,345.78%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $95.83
Upside: -44.69%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $55.82
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $245.04
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $102.86
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $44.06
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $380.92
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $16.30
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $56.75
Upside: -
Aug 12, 2016
Downgrades: Hold
Price Target: n/a
Current: $60.50
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $1.93
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $1.16
Upside: -
Jan 29, 2016
Upgrades: Buy
Price Target: n/a
Current: $37.74
Upside: -